SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

Thomas A. Zelniker, Stephen D. Wiviott, Itamar Raz, Kyungah Im, Erica L. Goodrich, Marc P. Bonaca, Ofri Mosenzon, Eri T. Kato, Avivit Cahn, Remo H.M. Furtado, Deepak L. Bhatt, Lawrence A. Leiter, Darren K McGuire, John P.H. Wilding, Marc S. Sabatine

Research output: Contribution to journalArticlepeer-review

1416 Scopus citations

Fingerprint

Dive into the research topics of 'SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials'. Together they form a unique fingerprint.

Medicine & Life Sciences